Home > Qtrly Results > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Quarterly Results Analysis [Mar2025]

SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹149 Cr ₹128 Cr ₹102 Cr ₹87 Cr ₹75 Cr ₹65 Cr ₹64 Cr ₹60 Cr
Expenses ₹131 Cr ₹113 Cr ₹90 Cr ₹77 Cr ₹65 Cr ₹58 Cr ₹57 Cr ₹53 Cr
Operating Income ₹18 Cr ₹15 Cr ₹12 Cr ₹10 Cr ₹9 Cr ₹7 Cr ₹6 Cr ₹6 Cr
Other Income ₹7 Cr ₹4 Cr ₹4 Cr ₹1 Cr ₹3 Cr ₹5 Cr ₹4 Cr ₹2 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹23 Cr ₹17 Cr ₹15 Cr ₹10 Cr ₹10 Cr ₹9 Cr ₹8 Cr ₹6 Cr
Profit After Tax ₹18 Cr ₹13 Cr ₹11 Cr ₹8 Cr ₹7 Cr ₹7 Cr ₹7 Cr ₹4 Cr
EPS ₹0.19 ₹0.14 ₹0.12 ₹0.08 ₹0.08 ₹0.07 ₹0.07 ₹0.05
Industry Peers & Returns1W1M1Y
SYNCOM FORMULATIONS (INDIA) -4.2% 34.1% 73.9%
SUN PHARMACEUTICAL INDUSTRIES 0.3% -5.5% 14.1%
DIVIS LABORATORIES 0.3% 7.9% 53.5%
CIPLA 1.7% -1.3% 1.7%
TORRENT PHARMACEUTICALS -1% -4.4% 16.3%
DR REDDYS LABORATORIES 3.1% 11.2% 8.2%
MANKIND PHARMA -4.5% -2.8% 9.4%
ZYDUS LIFESCIENCES 2.8% 7.8% -6.9%
LUPIN 1.9% -3.7% 22.4%

SYNCOM FORMULATIONS (INDIA) Quarterly Revenues

Revenues
Q-o-Q

16.74 %

Y-o-Y

99.64 %

Quarters Revenues % Change
Mar2025 ₹149 Cr
16.74
Dec2024 ₹128 Cr
24.65
Sep2024 ₹102 Cr
17.26
Jun2024 ₹87 Cr
17.01
Mar2024 ₹75 Cr
14.48
Dec2023 ₹65 Cr
2.04
Sep2023 ₹64 Cr
6.69
Jun2023 ₹60 Cr -

SYNCOM FORMULATIONS (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

20.52 %

Y-o-Y

88.37 %

Quarters Operating Profit % Change
Mar2025 ₹18 Cr
20.52
Dec2024 ₹15 Cr
21.12
Sep2024 ₹12 Cr
16.33
Jun2024 ₹10 Cr
10.93
Mar2024 ₹9 Cr
28.06
Dec2023 ₹7 Cr
14.86
Sep2023 ₹6 Cr
-0.82
Jun2023 ₹6 Cr -
Operating Margins
Q-o-Q

3.20 %

Y-o-Y

-5.70 %

Quarters Operating Margin% % Change
Mar2025 11.92%
3.20
Dec2024 11.55%
-2.86
Sep2024 11.89%
-0.75
Jun2024 11.98%
-5.22
Mar2024 12.64%
11.86
Dec2023 11.3%
12.55
Sep2023 10.04%
-7.04
Jun2023 10.8% -

SYNCOM FORMULATIONS (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

36.10 %

Y-o-Y

139.01 %

Quarters Profit After Tax % Change
Mar2025 ₹18 Cr
36.10
Dec2024 ₹13 Cr
17.04
Sep2024 ₹11 Cr
45.53
Jun2024 ₹8 Cr
3.11
Mar2024 ₹7 Cr
5.71
Dec2023 ₹7 Cr
7.54
Sep2023 ₹7 Cr
48.13
Jun2023 ₹4 Cr -
PAT Margins
Q-o-Q

16.68 %

Y-o-Y

19.74 %

Quarters PAT Margin(%) % Change
Mar2025 11.89 %
16.68
Dec2024 10.19 %
-6.17
Sep2024 10.86 %
24.11
Jun2024 8.75 %
-11.88
Mar2024 9.93 %
-7.63
Dec2023 10.75 %
5.39
Sep2023 10.2 %
38.78
Jun2023 7.35 % -

SYNCOM FORMULATIONS (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

35.71 %

Y-o-Y

137.50 %

Quarters EPS % Change
Mar2025 ₹0.19
35.71
Dec2024 ₹0.14
16.67
Sep2024 ₹0.12
50.00
Jun2024 ₹0.08
0.00
Mar2024 ₹0.08
14.29
Dec2023 ₹0.07
0.00
Sep2023 ₹0.07
40.00
Jun2023 ₹0.05 -

You may also like the below Video Courses